HR675-119

In Committee

Domestic SUPPLY Act of 2025

119th Congress Introduced Jan 23, 2025

Summary

What This Bill Does

This bill directs HHS, working with ASPR, CDC, Defense, and Homeland Security, to establish a domestic manufacturing partnership program for qualified personal protective equipment used in public health emergencies. The program uses contractual purchasing agreements with eligible domestic manufacturers to guarantee available supplies and manufacturing lines. The bill also bars federal, State, and local agencies from using federal funds to buy infectious-disease protective clothing or equipment made outside the United States, subject to Buy American-style exceptions and written justifications, and requires HHS and OSHA to report to Congress on PPE requirement changes since COVID-19 and their effects on physicians and other frontline medical professionals in 2020 and 2021.

Who Benefits and How

Domestic PPE manufacturers, healthcare workers, physicians, emergency preparedness planners, and patients benefit from a more reliable U.S. manufacturing base and purchasing commitments for masks, respirators, gowns, gloves, and other protective equipment used during public health emergencies. Domestic suppliers can gain contract opportunities and manufacturing-line stability.

Who Bears the Burden and How

HHS, ASPR, CDC, Defense, Homeland Security, federal procurement officials, State procurement officials, local procurement officials, and OSHA staff must create partnership rules, negotiate purchasing agreements, enforce domestic sourcing restrictions, document exceptions, and prepare the frontline worker safety report. Foreign PPE manufacturers and agencies that rely on foreign-made protective equipment may face reduced access to federally funded procurement.

Key Provisions

  • Establishes a domestic manufacturing partnership program for qualified PPE needed in public health emergencies.
  • Requires contractual purchasing agreements with eligible domestic PPE manufacturers within one year.
  • Requires agreements to guarantee supplies and manufacturing lines for public health emergency response.
  • Prohibits federally funded procurement of foreign-made infectious-disease protective clothing or equipment unless an exception applies.
  • Requires HHS and OSHA to report on COVID-era PPE requirement changes and frontline medical worker safety.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Create domestic PPE manufacturing partnerships, restrict federally funded infectious-disease protective equipment procurement to U.S.-made products, and require a report on PPE rule changes and frontline worker safety.

Key Policy Areas

Healthcare, Manufacturing, Procurement, Public Health

Primary Purpose

Create domestic PPE manufacturing partnerships, restrict federally funded infectious-disease protective equipment procurement to U.S.-made products, and require a report on PPE rule changes and frontline worker safety.

Policy Domains

Healthcare Manufacturing Procurement Public Health

Substantive provisions

Identified Gains
  • Domestic PPE manufacturers
  • Healthcare workers
  • Physicians
  • Emergency preparedness planners
  • Patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Patients: , ,
Physicians: , ,
Healthcare workers: , ,
Domestic PPE manufacturers: , ,
Emergency preparedness planners: , ,
Identified Costs
  • Department of Health and Human Services
  • ASPR
  • Centers for Disease Control and Prevention
  • Department of Defense
  • Department of Homeland Security
  • Federal procurement officials
  • State procurement officials
  • Local procurement officials
  • OSHA staff
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
ASPR: , ,
OSHA staff: , ,
Department of Defense: , ,
Local procurement officials: , ,
State procurement officials: , ,
Federal procurement officials: , ,
Department of Homeland Security: , ,
Department of Health and Human Services: , ,
Centers for Disease Control and Prevention: , ,

Legislative Progress

In Committee
Introduced Committee Passed
Jan 23, 2025

Mr. Griffith introduced the following bill; which was referred to …

Jan 23, 2025

Referred to the Committee on Energy and Commerce, and in …

Jan 23, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
4 mentions across 3 clauses
-4 negative

Department of Health and Human Services preparedness staff, Federal procurement officials, HHS reporting staff

Healthcare
4 mentions across 2 clauses
+4 positive

Frontline medical professionals, Healthcare workers needing PPE, Patients in public health emergencies

Manufacturing
2 mentions across 2 clauses
+2 positive

Domestic PPE manufacturers

State & Local Government
1 mention across 1 clause
-1 negative

State procurement officials

Foreign Entities
1 mention across 1 clause
-1 negative

Foreign PPE manufacturers

3/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Manufacturing Procurement Public Health
Actor Mappings
"Beneficiaries"
→ ['Manufacturers', 'Healthcare workers', 'Physicians', 'Planners', 'Patients']
"Administrators"
→ ['Department of Health and Human Services', 'ASPR', 'Centers for Disease Control and Prevention', 'Department of Defense', 'Department of Homeland Security', 'Procurement officials', 'OSHA staff']

Key Definitions

Terms defined in this bill

1 term
"" §Qualified personal protective equipment

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology